258 related articles for article (PubMed ID: 36005205)
41. Patient and provider perspectives of a new prenatal care model introduced in response to the coronavirus disease 2019 pandemic.
Peahl AF; Powell A; Berlin H; Smith RD; Krans E; Waljee J; Dalton VK; Heisler M; Moniz MH
Am J Obstet Gynecol; 2021 Apr; 224(4):384.e1-384.e11. PubMed ID: 33039393
[TBL] [Abstract][Full Text] [Related]
42. Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in "Back on track with screening" quality improvement projects.
Fisher-Borne M; Isher-Witt J; Comstock S; Perkins RB
Prev Med; 2021 Oct; 151():106681. PubMed ID: 34217422
[TBL] [Abstract][Full Text] [Related]
43. Patients' expectations of preventive measures of medical institutions during the SARS-CoV-2 pandemic in Germany in women with an increased risk of breast and ovarian cancer: a cross-sectional, web-based survey.
Schwab R; Droste A; Stewen K; Brenner W; Schmidt M; Hasenburg A
BMJ Open; 2022 May; 12(5):e060038. PubMed ID: 35545389
[TBL] [Abstract][Full Text] [Related]
44. Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States.
Lin C; Pham H; Zhu Y; Clingan SE; Lin LA; Murphy SM; Campbell CI; Sorrell TR; Liu Y; Mooney LJ; Hser YI
Drug Alcohol Depend; 2023 Jan; 242():109711. PubMed ID: 36462230
[TBL] [Abstract][Full Text] [Related]
45. Digital Health Technology for Remote Care in Primary Care During the COVID-19 Pandemic: Experience from Dubai.
AbdulRahman M; Al-Tahri F; AlMehairi MK; Carrick FR; Aldallal AMR
Telemed J E Health; 2022 Aug; 28(8):1100-1108. PubMed ID: 34981953
[No Abstract] [Full Text] [Related]
46. Women with Visual Impairment and Insured by Medicaid or Medicare Are Less Likely to Receive Recommended Screening for Breast and Cervical Cancers.
Xu X; Mann JR; McDermott SW; Deroche CB; Gustafson E; Hardin JW
Ophthalmic Epidemiol; 2017 Jun; 24(3):168-173. PubMed ID: 27552166
[TBL] [Abstract][Full Text] [Related]
47. Differences in Utilization of Nonvideo Telemedicine Visits for Dermatologic Concerns in Underserved Populations During the COVID-19 Pandemic.
Lee MS; Guo LN; Wang W; Nambudiri VE
Telemed J E Health; 2021 Aug; 27(8):827-834. PubMed ID: 34297903
[No Abstract] [Full Text] [Related]
48. Breast Medical Oncologists' Perspectives of Telemedicine for Breast Cancer Care: A Survey Study.
Stavrou E; Qiu J; Zafar A; Tramontano AC; Isakoff S; Winer E; Schrag D; Manz C
JCO Oncol Pract; 2022 Sep; 18(9):e1447-e1453. PubMed ID: 35671420
[TBL] [Abstract][Full Text] [Related]
49. Telehealth Availability and Use of Related Technologies Among Medicare-Enrolled Cancer Survivors: Cross-sectional Findings From the Onset of the COVID-19 Pandemic.
Lama Y; Davidoff AJ; Vanderpool RC; Jensen RE
J Med Internet Res; 2022 Jan; 24(1):e34616. PubMed ID: 34978531
[TBL] [Abstract][Full Text] [Related]
50. Disparities in telemedicine utilization among surgical patients during COVID-19.
Lattimore CM; Kane WJ; Fleming MA; Martin AN; Mehaffey JH; Smolkin ME; Ratcliffe SJ; Zaydfudim VM; Showalter SL; Hedrick TL
PLoS One; 2021; 16(10):e0258452. PubMed ID: 34624059
[TBL] [Abstract][Full Text] [Related]
51. Changes in breast cancer screening rates among 32 community health centers during the COVID-19 pandemic.
Fedewa SA; Cotter MM; Wehling KA; Wysocki K; Killewald R; Makaroff L
Cancer; 2021 Dec; 127(23):4512-4515. PubMed ID: 34436765
[TBL] [Abstract][Full Text] [Related]
52. Negative impact of the COVID-19 state of emergency on breast cancer screening participation in Japan.
Toyoda Y; Katanoda K; Ishii K; Yamamoto H; Tabuchi T
Breast Cancer; 2021 Nov; 28(6):1340-1345. PubMed ID: 34241799
[TBL] [Abstract][Full Text] [Related]
53. Impact of the COVID-19 Pandemic on Delays to Breast Cancer Surgery: Ripples or Waves?
Chung SH; Romatoski KS; Rasic G; Beaulieu-Jones BR; Kenzik K; Merrill AL; Tseng JF; Cassidy MR; Sachs TE
Ann Surg Oncol; 2023 Oct; 30(10):6093-6103. PubMed ID: 37526751
[TBL] [Abstract][Full Text] [Related]
54. Pandemic-Triggered Adoption of Telehealth in Underserved Communities: Descriptive Study of Pre- and Postshutdown Trends.
Xu P; Hudnall M; Zhao S; Raja U; Parton J; Lewis D
J Med Internet Res; 2022 Jul; 24(7):e38602. PubMed ID: 35786564
[TBL] [Abstract][Full Text] [Related]
55. Rural-Urban Disparities in Telemedicine Use Among U.S. Adults with Cancer.
Lee M; Tsai MH; Tillewein H; Luckey GS
Telemed J E Health; 2024 Feb; ():. PubMed ID: 38301205
[No Abstract] [Full Text] [Related]
56. Disparities in Telemedicine Utilization for Urology Patients During the COVID-19 Pandemic.
Javier-DesLoges J; Meagher M; Soliman S; Yuan J; Hakimi K; Ghali F; Nalawade V; Patel DN; Monga M; Murphy JD; Derweesh I
Urology; 2022 May; 163():76-80. PubMed ID: 34979219
[TBL] [Abstract][Full Text] [Related]
57. Disparities in Outpatient and Telehealth Visits During the COVID-19 Pandemic in a Large Integrated Health Care Organization: Retrospective Cohort Study.
Qian L; Sy LS; Hong V; Glenn SC; Ryan DS; Morrissette K; Jacobsen SJ; Xu S
J Med Internet Res; 2021 Sep; 23(9):e29959. PubMed ID: 34351865
[TBL] [Abstract][Full Text] [Related]
58. Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity.
Richman I; Tessier-Sherman B; Galusha D; Oladele CR; Wang K
J Natl Cancer Inst; 2023 Feb; 115(2):139-145. PubMed ID: 36069622
[TBL] [Abstract][Full Text] [Related]
59. Expansion of telemedicine during COVID-19 at a VA specialty clinic.
Balut MD; Wyte-Lake T; Steers WN; Chu K; Dobalian A; Ziaeian B; Heyworth L; Der-Martirosian C
Healthc (Amst); 2022 Mar; 10(1):100599. PubMed ID: 34999492
[TBL] [Abstract][Full Text] [Related]
60. Perspectives of older women with early breast cancer on telemedicine during post-primary treatment.
Buse CR; Kelly EAO; Muss HB; Nyrop KA
Support Care Cancer; 2022 Dec; 30(12):9859-9868. PubMed ID: 36378342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
